Summary
The aim of this study was to investigate whether the newly synthesized bisphosphonic acidlinked N-Lost derivative BAD retains bone-seeking and cytostatic properties. The paper describes experiments on mutagenicity in vitro and on toxicity in vivo. BAD is characterized by very low mutagenic activity toward histidine auxotrophic Salmonella typhimurium strains. Cytotoxic effects were tested in rat osteosarcoma and in Walker carcinosarcoma 256B. The LD50 of i.v. injected BAD was 146 mg/kg. Acute toxicity is probably caused by calcium complexing of the bisphosphonate part of the molecule. Labeling experiments showed moderate accumulation in bone and osteosarcoma, as well as in lung metastases. BAD effected high tumor growth inhibition in osteosarcoma and Walker carcinosarcoma-bearing rats and marked prolongation of survival; histologic and radiographic examination revealed rapid calcification of osteosarcoma and lung metastases. BAD-pretreatment produced protective effects against osteolysis induced by intratibially implanted Walker carcinosarcoma ascites cells. The cytostatic efficacy of equitoxic doses of BAD in rat osteosarcoma is comparable to that of dacarbazine and in Walker carcinosarcoma to that of melphalan.
Similar content being viewed by others
References
Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347–364
Benedict WF, Baker MS, Haroun L, Choi E, Ames BN (1977) Mutagenicity of Cancer Chemotherapeutic. Agents in the Salmonella/Microsome Test. Cancer Res 37:2209–2213
Bolognose C, Cesarone CF, Santi L (1979) Standardization of alkaline elution procedure using X-ray damaged nuclear DNA. Tumori 65:511–516
Canfield R, Rosner W, Skinner J, McWhorter J, Resnick L, Feldman F, Kammerman S, Ryan K, Kunigonis M, Bohne W (1977) Diphosphonate therapy of Pagets' disease in bone. I. Clin Endocrinol Metab 44:96–109
Cavalli-Sforza L (1974) Biometrie — Grundzüge biologischer medizinischer Statistik 6. Fischer Verlag, Stuttgart, pp 33–34
Delamore IW (1982) Hypercalcaemia and mycloma. Br J Haematol 51:507–509
Delbrück HG, Allouche H, Jasmin C, Morin M, Deml F, Aughilers L, Masse R, Lafuma I (1980) Bone tumors induced in rats with radioactive cerium. Br J Cancer 41:809–815
Delbrück H, Nell G, Arf A, Thiel H, Reikowski H, Siepmann H (1982) Ultrasonographic evaluation of structure, histology, kinetics and early chemotherapeutic response in tumors (abstract). Blut 45:221
Delbrück H (1982) Experimentelle Untersuchungen an einem Osteosarkommodell. Habilitationsschrift, Homburg/Saar
Eisenhut M, Berberich R, Kimmig B, Wingen F, Georgi P, Oberhausen E, zum Winkel K (1985) Line 131J-markierte Benzylidendiphosphonsäure für die palliative Therapie von Knochenmetastasen: Kinetik und Wirkung 2. Tübinger Knochensymposium 11–12 Jan 1985, Tübingen, FRG
Felix R, Fleisch H (1981) The effect of diphosphonates on periostal and bone cells in culture. Experientia 37:817–819
Fogelman I (1982) Diphosphonate bone scanning agents — Current concepts. Eur J Nucl Med 7:506–509
Frijlink WB, Bijvoet OLM, te Velte J, Heynen G (1979) Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (A.P.D.). Lancet I:799–803
Guaitani A, Polentarutti N, Filippeschi S, Marmoti L, Corti F, Italia C, Coccioli G, Donelli MG, Mantovani A, Gerattini S (1984) Effects of Disodium Etidronate in murine tumor models. Eur J Cancer Clin Oncol 20:685–693
Guilland DF, Sallis ID, Fleisch H (1974) The effect of two diphosphonates on the handling of calcium by rat kidney mitochondria in vitro. Calcif Tissue Res 15:303–314
Habs M (1980) Methoden, Ergebnisse und Probleme der experimenteller Chemotherapie. In: Schmähl D (Hrsg) Maligne Tumoren, Entstehung, Wachstum, Chemotherapie. Editio Cantor Aulendorf p 467
Habs M, Habs H (1980) Durchführung und Auswertung von Tierversuchen zur Cancerogenese. In: Schmähl D (Hrsg) Maligne Tumoren. Editio Cantor Aulendorf (3rd ed) pp 42–47
Heaney RP, Saville PD (1976) Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol Ther 20:593–604
Heins A, Plöger W (1980) Henkel-Referate 16, Excerpts of Henkel Research Papers, 19–25. Henkel Chemical Corp., 600, Madison Avenue, New York, NJ 20022
Hensel H, Schäfer K (1974) Effects of calcium on warm and cold receptors. Pflügers Arch 352:87
IARC International Agency for Research on Cancer (1982) Chemicals, industrial processes and industries associated with cancer in humans, IARC, Lyons (IARC monographs on the evaluation of the carcinogenic risk of chemicals to human, supplement)
Jung A, Fleisch H (1981) Les diphosphonates dans le traitement des metastases osseuses. Schweiz Med Wochenschr 111:1878–1882
Jung A (1982) Comparison of two parenteral diphosphonates in Hypercalcemia of malignancy. Am J Med 72:221–226
Krempien B, Pfeilschifter J, Minne H (1982) Influence of (3-Amino-1-Hydroxypropylidene)-1,1-bisphosphonate (APD) on bone remodelling. In: Silverman (ed) Current advances in sceletogenesis. HC Slavkin, Amsterdam, Oxford, Privetion, pp 117–122
Loehrke H, Hesse B (1981) Das Walker Ca 256 auf der SD-Ratte. Tumorsteckbrief, Deutsches Krebsforschungszentrum Heidelberg, Institut für experimentelle Pathologie, Tumorbank
Menge M (1983) Hemmung der Knochengewebsbildung durch Propan-2,2-diphosphonat. Fortschr Med 39:1787–1791
Miune H, Ziegler R, Schmitt W, Hilgard P (1971) Die hypercalcämische Aktivität des Walker-Karzinosarkoms 256 bei der Ratte. Schweiz Med Wochenschr 101:481
Mundy GP (1980) Osteoclasts activating factors. Metab Bone Dis Relat Res 2:172
Nakashima H, Ochi H, Yasni N, Hamada H, Ono K (1982) Uptake and localisation of 99mTc-Methylene-Diphosphonate in mouse osteosarcoma. Eur J Nucl Med 7:531–535
Plasmans CMT, Jap PHK, Kuijpers W, Slooff TJJH (1980) Influence of diphosphonate on the cellular aspect of young bone tissue. Calcif Tissue Int 32:247–256
Pool BL, Röper H, Röper S, Romruen K (1984) Mutagenicity studies on N-nitrosated products of the maillard browning reaction. N-nitroso-fructose-amino acids. Food Chem Toxicol 22:797–801
Radl J, Croese JW, Zurcher C et al. (1985) Influence of treatment with APD-Bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer 55:1030–1040
Rieche K (1984) Carcinogenicity of antineoplastic agents in man. Cancer Treat Rev 11:39–67
Saackel LR (1974) Elektronische Auswertung von Mikroradiogrammen. Biomed Tech 19:10–14
Schmähl D, Habs M, Lorenz M, Wagner I Occurrence of second tumors in man after anticancer drug treatment. Cancer Treat Rev 9:167–194
Schnur W (1984) Palliative pain therapy among bone metastases. Arzneimitteltherapie 4:128
Senekowitsch R, Kriegel H (1980) Der Einfluß einer Chemotherapie auf die Retention von 99mTc-Methylendiphosphonat im Osteosarkom der Maus. Nucl Med 19(4):200–205
Sterz H, Hebold G (1980) Analysis of radiographs in reproduction toxicology by means of densitometry and planimetry. In: Merker HJ, Nau H, Neubert D (eds) Teratology of the limbs. De Gruyter, Berlin, pp 373–382
Ther L (1965) In: Grundlagen der experimentellen Arzneimittelforschung. Wiss. Verlagsgesellschaft Stuttgart, pp 82–95
Weber E (1980) Adam — Statistische Auswertung biomedizinischer Daten. Teil I. Deutsches Krebsforschungszentrum, Heidelberg
Weber E (1982) Survival — Statistische Auswertung biomedizinischer Daten. Teil II. Deutsches Krebsforschungszentrum, Heidelberg
Wingen F, Schmähl D, Berger MR, Spring H (1984) Intraosseously transplantable osteosarcoma with regulary disseminating pulmonary metastases in rats. Cancer Lett 23:201–211
Wingen F, Schmähl D (1985) Distribution of 3-Amino-1-hydroxypropane-1,1-diphosphonic Acid (APD) in rats and effects on rat osteosarcoma. Arzneimittelforschung 35(II), 1565–1571
Author information
Authors and Affiliations
Additional information
Dedicated to Professor P. Obrecht, Basel, on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Wingen, F., Sterz, H., Blum, H. et al. Synthesis, antitumor activity, distribution and toxicity of 4-[4-[Bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma. J Cancer Res Clin Oncol 111, 209–219 (1986). https://doi.org/10.1007/BF00389236
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00389236